0
0
A new study published in JAMA Oncology has found that cancer patients who quit smoking within six months of their diagnosis can extend their lifespan by an average of two years. The study underscores the importance of smoking cessation programs in cancer care.
Key takeaways from the study
- Patients who quit smoking within six months of their cancer diagnosis experienced a significant survival benefit.
- The findings held true for all cancer types studied.
- Experts emphasize the need for structured smoking cessation programs to be offered to all cancer patients.
Smoking cessation programs crucial for improved outcomes
The study highlights the critical role that quitting smoking plays in improving the survival rates of cancer patients. Dr. David Marshall, chair of Radiation Medicine at MUSC Hollings Cancer Center, stressed the importance of smoking cessation, even for patients diagnosed with non-smoking-related cancers.
The findings support the widespread adoption of structured tobacco cessation programs in cancer care. Dr. Raymond DuBois, director of Hollings, pointed out that currently, only 40% of cancer centers offer such programs. He emphasized the urgent need for all cancer patients to receive support to quit smoking, as smoking can hamper the immune response and reduce the effectiveness of cancer treatment.
This study reinforces the importance of smoking cessation for overall health and well-being, especially for cancer patients. By quitting smoking, patients can significantly improve their chances of survival and experience a better quality of life.
